Researchers from the National Healthcare Group (NHG)’s Institute of Mental Health (IMH) and Agency for Science, Technology and Research (A*STAR) have made strides in understanding the connection between the immune system and resistance to antipsychotic medications in schizophrenia, using changes in immune cell populations to predict potential treatment resistance and initiate the most appropriate treatment sooner.
Age-related macular degeneration market expected to reach $27.5bn across 7MM by 2031
Share this article KOLs interviewed by GlobalData have emphasised the need for improvement in several AMD therapies. Credit: GlobalData. The age-related macular degeneration (AMD) market